Floatz logo

Ivabradine

Myocardial Ischemia

Xintong Pharmacy CompanySmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Myocardial Ischemia cohort.

Asset / SponsorPhaseRating
Ranolazine
East Carolina University
Phase 4A
Aspirin
Rajaie Cardiovascular Medical and Research Center
Phase 4BBB
Atenolol
Xintong Pharmacy Company
Phase 4BBB
3-(2,2,2-TRIMETHYLDIAZANIUMYL)PROPANOATE
Burnasyan Federal Medical Biophysical Center
Phase 4BB
Nebido
Sheffield Teaching Hospitals NHS Foundation Trust
Phase 4BB

View all 27 →

Same molecule, other indications

Ivabradine is also rated in:

long COVID-19Active
B
Indicative · Phase 2
62 / 100
View asset →
dysautonomiaDormant
CCC
Indicative · Phase 2
53 / 100
View asset →
cancer-related conditionDormant
CCC
Indicative · Phase 2
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →